Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

IRENE HELEN MANNERING

Allopathic & Osteopathic Physicians Dermatology

NPI
1023300977
CMS profile
847935
Location
SPARKS, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$2,035.30

98 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,713.14 94
Education $322.16 4

By paying entity

PY2025 · entire year · sorted by reported total

Page 1 of 2; records 1–50 of 98 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

IRENE HELEN MANNERING

NPI 1023300977 · CMS profile ID 847935

Allopathic & Osteopathic Physicians / Dermatology

SPARKS, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 98 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1023300977?year=2025&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
IRENE HELEN MANNERING, NPI 1023300977, CMS profile ID 847935. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 98 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1023300977?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). IRENE HELEN MANNERING, NPI 1023300977, CMS profile ID 847935. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 98 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1023300977?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
IRENE HELEN MANNERING, NPI 1023300977, CMS profile ID 847935, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 98 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1023300977?year=2025&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

98 matching records · $2,035.30 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 98 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 98.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $11.2612/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203012183 CMS
Novartis Pharmaceuticals Corporation $23.1712/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200669972 CMS
Regeneron Healthcare Solutions, Inc. $33.1412/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212982343 CMS
Janssen Biotech, Inc. $21.4212/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175291601 CMS
ABBVIE INC. $9.8412/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203012181 CMS
GENZYME CORPORATION $24.3011/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233323890 CMS
Galderma Laboratories, L.P. $16.9011/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234675501 CMS
UCB, Inc. $17.0011/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224636518 CMS
Amgen Inc. $28.3711/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228281075 CMS
E.R. Squibb & Sons, L.L.C. $12.0811/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184514017 CMS
Biofrontera Inc. $21.0910/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208906414 CMS
Biofrontera Inc. $24.1710/29/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1208906416 CMS
ABBVIE INC. $6.9310/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203012179 CMS
Lilly USA, LLC $29.8510/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186654667 CMS
LEO Pharma Inc. $15.0910/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252021315 CMS
Novartis Pharmaceuticals Corporation $22.6810/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200662724 CMS
ABBVIE INC. $24.4010/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203012177 CMS
GENZYME CORPORATION $17.4709/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233323884 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $18.2109/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251003786 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $99.0009/11/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1251003782 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $23.0309/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251003790 CMS
Lilly USA, LLC $22.8608/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186594526 CMS
Novartis Pharmaceuticals Corporation $24.2808/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200662720 CMS
Novartis Pharmaceuticals Corporation $24.2808/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200662722 CMS
ABBVIE INC. $21.9208/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203012175 CMS
Lilly USA, LLC $11.6608/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186585384 CMS
Lilly USA, LLC $0.5908/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186616844 CMS
Amgen Inc. $12.9007/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227049498 CMS
Janssen Biotech, Inc. $7.8407/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175291551 CMS
ABBVIE INC. $17.8907/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203012173 CMS
Regeneron Healthcare Solutions, Inc. $20.6607/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212982341 CMS
E.R. Squibb & Sons, L.L.C. $5.4207/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184513977 CMS
Organon LLC $7.3807/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1237639112 CMS
Janssen Biotech, Inc. $19.1307/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175291683 CMS
Janssen Biotech, Inc. $21.3707/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175291674 CMS
Lilly USA, LLC $27.7207/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186594524 CMS
E.R. Squibb & Sons, L.L.C. $18.8807/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184513985 CMS
Lilly USA, LLC $17.1206/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186628813 CMS
Novartis Pharmaceuticals Corporation $26.5306/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200662718 CMS
Amgen Inc. $27.6406/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228281073 CMS
ABBVIE INC. $8.0706/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203012171 CMS
Lilly USA, LLC $5.0806/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186640659 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $24.4906/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1220081974 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.9006/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222750054 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $23.9806/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1220081972 CMS
Janssen Biotech, Inc. $19.4905/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175291447 CMS
Regeneron Healthcare Solutions, Inc. $32.6305/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212982339 CMS
PFIZER INC. $33.1805/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229835991 CMS
ABBVIE INC. $9.3105/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203012169 CMS
Janssen Biotech, Inc. $24.8105/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175291649 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $273.25 13
PY2020 $523.10 24
PY2021 $518.25 27
PY2022 $971.19 44
PY2023 $1,702.28 68
PY2024 $3,145.18 109
PY2025 $2,035.30 98

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $107,451.74 26
PY2024 Principal investigator $138,021.79 22

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

22 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $1,485.36 12/31/2024 Non-covered Recipient Entity
SKIN CANDER AND DERMATOLOGY INST
M23-702 Skyrizi Ph4 PsO (Special Areas-Genital-Scalp) No dispute reported 06/30/2026 1100765497
Principal investigator 1 ABBVIE INC. $5,013.20 12/05/2024 Non-covered Recipient Entity
MOUNTAIN WEST DERM-BLACKHART PLLC
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1100759791
Principal investigator 1 ABBVIE INC. $1,076.70 12/05/2024 Non-covered Recipient Entity
MOUNTAIN WEST DERM-BLACKHART PLLC
Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis No dispute reported 06/30/2026 1100759793
Principal investigator 1 ABBVIE INC. $8,869.50 11/07/2024 Non-covered Recipient Entity
MOUNTAIN WEST DERM-BLACKHART PLLC
A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy No dispute reported 06/30/2026 1100754419
Principal investigator 1 ABBVIE INC. $6,483.00 11/07/2024 Non-covered Recipient Entity
MOUNTAIN WEST DERM-BLACKHART PLLC
Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis No dispute reported 06/30/2026 1100754421
Principal investigator 1 ABBVIE INC. $12,035.00 10/03/2024 Non-covered Recipient Entity
MOUNTAIN WEST DERM-BLACKHART PLLC
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up) No dispute reported 06/30/2026 1100747196
Principal investigator 1 ABBVIE INC. $6,064.80 10/03/2024 Non-covered Recipient Entity
MOUNTAIN WEST DERM-BLACKHART PLLC
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1100747276
Principal investigator 1 ABBVIE INC. $8,659.20 10/03/2024 Non-covered Recipient Entity
MOUNTAIN WEST DERM-BLACKHART PLLC
Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis No dispute reported 06/30/2026 1100747278
Principal investigator 1 ABBVIE INC. $11,092.03 09/04/2024 Non-covered Recipient Entity
MOUNTAIN WEST DERM-BLACKHART PLLC
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1100740996
Principal investigator 1 ABBVIE INC. $11,678.00 08/02/2024 Non-covered Recipient Entity
MOUNTAIN WEST DERM-BLACKHART PLLC
Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis No dispute reported 06/30/2026 1100733816
Principal investigator 1 ABBVIE INC. $9,276.90 08/02/2024 Non-covered Recipient Entity
MOUNTAIN WEST DERM-BLACKHART PLLC
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1100733854
Principal investigator 1 ABBVIE INC. $5,538.30 07/05/2024 Non-covered Recipient Entity
MOUNTAIN WEST DERM-BLACKHART PLLC
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1100726944
Principal investigator 1 ABBVIE INC. $8,921.20 06/06/2024 Non-covered Recipient Entity
MOUNTAIN WEST DERM-BLACKHART PLLC
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1100722266
Principal investigator 1 ABBVIE INC. $5,788.00 05/09/2024 Non-covered Recipient Entity
MOUNTAIN WEST DERM-BLACKHART PLLC
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1100717888
Principal investigator 1 ABBVIE INC. $9,685.70 04/04/2024 Non-covered Recipient Entity
MOUNTAIN WEST DERM-BLACKHART PLLC
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1100712488
Principal investigator 1 ABBVIE INC. $3,945.80 03/07/2024 Non-covered Recipient Entity
MOUNTAIN WEST DERM-BLACKHART PLLC
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1100706184
Principal investigator 1 ABBVIE INC. $6,117.60 02/15/2024 Non-covered Recipient Entity
MOUNTAIN WEST DERM-BLACKHART PLLC
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1100703942
Principal investigator 1 ABBVIE INC. $2,397.70 02/01/2024 Non-covered Recipient Entity
MOUNTAIN WEST DERM-BLACKHART PLLC
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1100701826
Principal investigator 1 ABBVIE INC. $2,170.70 02/01/2024 Non-covered Recipient Entity
MOUNTAIN WEST DERM-BLACKHART PLLC
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1100701828
Principal investigator 1 ABBVIE INC. $1,419.40 02/01/2024 Non-covered Recipient Entity
MOUNTAIN WEST DERM-BLACKHART PLLC
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1100701830
Principal investigator 1 ABBVIE INC. $8,133.00 01/19/2024 Non-covered Recipient Entity
MOUNTAIN WEST DERM-BLACKHART PLLC
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1100700760
Principal investigator 1 ABBVIE INC. $2,170.70 01/19/2024 Non-covered Recipient Entity
MOUNTAIN WEST DERM-BLACKHART PLLC
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy (Step-Up HS) No dispute reported 06/30/2026 1100700762